Dmitry Balyasny’s Inozyme Pharma INZY Stock Holding History

Dmitry Balyasny’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-39,003	Closed	-$156K	–	3175
2025 Q2	$156K	Buy	+39,003	New	+$96.6K	﹤0.01%	2639
2024 Q2	–	Sell	-31,380	Closed	-$240K	–	2829
2024 Q1	$240K	Buy	+31,380	New	+$172K	﹤0.01%	2339

Dmitry Balyasny's INZY Position: Q3 2025 in Review

Dmitry Balyasny sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 39,003 shares — an estimated $156K sold.

Dmitry Balyasny first reported a position in INZY in Q1 2024 and held it in 2 quarters. The position peaked at $240K in Q1 2024. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

Dmitry Balyasny reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
Dmitry Balyasny sold 39,003 Inozyme Pharma shares in Q3 2025, an estimated $156K.
Dmitry Balyasny first reported a position in Inozyme Pharma in Q1 2024 and held it in 2 quarters.
Dmitry Balyasny's Inozyme Pharma position peaked at $240K in Q1 2024.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.